PD57-01 MR/US FUSION-GUIDED PROSTATE BIOPSY IMPROVES CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTION FOR BIOPSY-NAIVE PATIENTS ACROSS DIVERSE PRACTICE SETTINGS

2020 ◽  
Vol 203 ◽  
pp. e1193
Author(s):  
Brett Watson* ◽  
Ji Qi ◽  
Anna Johnson
Keyword(s):  
Prostate Cancer ◽  
Cancer Detection ◽  
Prostate Biopsy ◽  
Prostate Cancer Detection ◽  
Clinically Significant

RACE IS NOT A PREDICTOR OF PROSTATE CANCER DETECTION ON REPEAT PROSTATE BIOPSY

2004 ◽  
Vol 172 (5) ◽  
pp. 1853-1855 ◽  
Author(s):  
BRETT S. CARVER ◽  
CALEB B. BOZEMAN ◽  
WALTER J. SIMONEAUX ◽  
DENNIS D. VENABLE ◽  
MICHAEL W. KATTAN ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Detection ◽  
Prostate Biopsy ◽  
Prostate Cancer Detection

scholarly journals Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI

2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Maudy C. W. Gayet ◽  
Anouk A. M. A. van der Aa ◽  
Harrie P. Beerlage ◽  
Bart Ph Schrier ◽  
Maaike Gielens ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Detection ◽  
Prostate Biopsy ◽  
Detection Rates ◽  
Prostate Biopsies ◽  
Significant Difference ◽  
Significant Pathology ◽  
Study Population ◽  
Clinically Significant ◽  
Control Study

Objective. To compare prostate cancer detection rates (CDRs) and pathology results with targeted prostate biopsy (TB) and systematic prostate biopsy (SB) in biopsy-naive men. Methods. An in-patient control study of 82 men undergoing SB and subsequent TB in case of positive prostate MRI between 2015 and 2017 in the Jeroen Bosch Hospital, the Netherlands. Results. Prostate cancer (PCa) was detected in 54.9% with 70.7% agreement between TB and SB. Significant PCa (Gleason score ≥7) was detected in 24.4%. The CDR with TB and SB was 35.4% and 48.8%, respectively (p=0.052). The CDR of significant prostate cancer with TB and SB was both 20.7%. Clinically significant pathology upgrading occurred in 7.3% by adding TB to SB and 22.0% by adding SB to TB. Conclusions. There is no statistically significant difference between CDRs of SB and TB. Both SB and TB miss significant PCas. Moreover, pathology upgrading occurred more often by adding SB to TB than vice versa. This indicates that the omission of SB in this study population might not be justified.

Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI‐RADS Version 2.1

2020 ◽  
Vol 53 (1) ◽  
pp. 283-291
Author(s):  
Tsutomu Tamada ◽  
Ayumu Kido ◽  
Akira Yamamoto ◽  
Mitsuru Takeuchi ◽  
Yoshiyuki Miyaji ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Detection ◽  
Multiparametric Mri ◽  
Prostate Cancer Detection ◽  
Clinically Significant

Clinically significant prostate cancer detection on MRI: A radiomic shape features study

2019 ◽  
Vol 116 ◽  
pp. 144-149 ◽  
Author(s):  
Renato Cuocolo ◽  
Arnaldo Stanzione ◽  
Andrea Ponsiglione ◽  
Valeria Romeo ◽  
Francesco Verde ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Detection ◽  
Shape Features ◽  
Prostate Cancer Detection ◽  
Clinically Significant

Dutasteride Prior to Contrast-Enhanced Colour Doppler Ultrasound Prostate Biopsy Increases Prostate Cancer Detection

2008 ◽  
Vol 53 (1) ◽  
pp. 112-117 ◽  
Author(s):  
Michael Mitterberger ◽  
Germar Pinggera ◽  
Wolfgang Horninger ◽  
Hannes Strasser ◽  
Ethan Halpern ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Doppler Ultrasound ◽  
Cancer Detection ◽  
Prostate Biopsy ◽  
Colour Doppler ◽  
Prostate Cancer Detection ◽  
Colour Doppler Ultrasound ◽  
Contrast Enhanced
Sign in / Sign up

Export Citation Format

Share Document